Sign In
Buy IMGN
$31.23
+0 (+0%)
At Close: May 08, 2024
3 Stocks at the Forefront of Medical Innovation
08:23pm, Monday, 25'th Dec 2023
Innovation in the medical world is undoubtedly a fundamental pillar in the development of humanity. There are great companies within the biotech sector doing wonderful work, research, and developments
5 Reasons to be Bullish into 2024
04:32pm, Monday, 11'th Dec 2023
2023: Predicting is Futile, Interpreting is Priceless
WALTHAM, Mass.--(BUSINESS WIRE)--ImmunoGen Presents Findings from Newly Diagnosed AML Cohorts in Phase 1b/2 Study of Pivekimab Sunirine with Azacitidine and Venetoclax at ASH.
Market Movers: Why Big Players Are Investing Millions in These 3 Stocks
11:23am, Friday, 08'th Dec 2023
Certain smart money stocks catch the discerning eye of big players in investing, drawing in substantial investments. Delving into the strategies and growth patterns of three companies reveals intrigui
Abbvie to focus on smaller deals after Cerevel and ImmunoGen buyout
09:51am, Thursday, 07'th Dec 2023
U.S. drugmaker Abbvie said on Thursday it does not expect any transactions similar to its $8.7 billion buyout of Cerevel Therapeutics in the foreseeable future and would instead focus on smaller deals
Small Cap, Big Potential: 3 Russell 2000 Stocks to Watch
03:26pm, Wednesday, 06'th Dec 2023
Small-cap stocks are a good option for investors looking to gain exposure to typically newer companies offering niche products and services that may have the potential for massive share price apprecia
Are You Looking for a Top Momentum Pick? Why ImmunoGen (IMGN) is a Great Choice
01:32pm, Monday, 04'th Dec 2023
Does ImmunoGen (IMGN) have what it takes to be a top stock pick for momentum investors? Let's find out.
AbbVie: 4 Hidden Keys Investors Must Know To Judge ImmunoGen Acquisition
05:00pm, Sunday, 03'rd Dec 2023
AbbVie has agreed to acquire ImmunoGen for $10 billion, nearly double its previous trading price. The acquisition provides AbbVie with a commercial-stage company and a flagship drug that generated $10
ImmunoGen (IMGN) Just Flashed Golden Cross Signal: Do You Buy?
11:20am, Friday, 01'st Dec 2023
From a technical perspective, ImmunoGen (IMGN) is looking like an interesting pick, as it just reached a key level of support. IMGN recently overtook the 20-day moving average, and this suggests a sho
AbbVie (ABBV) to Acquire ImmunoGen (IMGN) for $10.1 Billion
07:31am, Friday, 01'st Dec 2023
AbbVie (ABBV) offers to buy ImmunoGen (IMGN) for approximately $10.1 billion, which will diversify its oncology pipeline across solid tumors and hematologic malignancies.
ImmunoGen stock nearly doubled on Thursday: what happened?
02:54pm, Thursday, 30'th Nov 2023
Shares of ImmunoGen Inc (NASDAQ: IMGN) close to doubled this morning after AbbVie Inc (NYSE: ABBV) said it will buy the cancer therapies company for $10.1 billion. ImmunoGen stock priced at a massive
Pay Attention to These 3 Stock Movers Today
02:49pm, Thursday, 30'th Nov 2023
The Dow is sprinting to the finish line this November, ahead of a historically bullish month.
Biotech stocks jump on AbbVie deal to buy cancer drugmaker ImmunoGen for $10 billion
12:29pm, Thursday, 30'th Nov 2023
Other biotech companies developing ADCs, which are among the hottest areas in the pharmaceutical industry, jumped on the news of AbbVie's buyout of ImmunoGen.
AbbVie Pays $10.1 Billion for ImmunoGen to Expand Its Cancer Drug Portfolio
12:16pm, Thursday, 30'th Nov 2023
ImmunoGen (IMGN) shares skyrocketed over 80% in early trading Thursday after AbbVie (ABBV) agreed to buy the rival biotech firm for $10.1 billion to expand its cancer drug portfolio.
Why Is ImmunoGen (IMGN) Stock Up 81% Today?
10:38am, Thursday, 30'th Nov 2023
ImmunoGen (NASDAQ: IMGN ) stock is seeing massive gains on Thursday after the company announced an acquisition deal with AbbVie (NYSE: ABBV ). A press release from AbbVie reveals that ImmunoGen is bei
